Riskpilot← Back to searchSign inGet full accessMedinensis AB
ABActiveOrg 5569971574Vallkärravägen 17General medical practice activities · NACE 8621Est. 20140 employees
Revenue 2025
SEK 233K
EBITDA margin
88.9%
+2169% vs 2024
Equity ratio
83.9%
Financial strength
Net profit 2025
SEK 174K
+2028% vs 2024
| Revenue | SEK 233K | — |
| EBITDA | SEK 207K | +2169% |
| Net profit | SEK 174K | +2028% |
| Total assets | SEK 336K | +176% |
| Equity | SEK 282K | +159% |
| Employees | 0 | — |
Legal name
Medinensis AB
Org number
5569971574
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 december 2014
Share capital
SEK 50 400
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsulttjänster inom hälso- och sjukvård samt forskning, utbildning, rådgivning och konsultverksamhet inom medicin och life science, äga och förvalta aktier och annan lös och fast egendom och därmed förenlig verksamhet.
Address
Vallkärravägen 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 54 | 0 | 0 | 0 | 233 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 23 | −12 | −20 | −10 | 207 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | 23 | −12 | −20 | −10 | 207 |
| Net financials | — | — | 0 | 1 | 1 |
| Profit before tax | 23 | −12 | −19 | −9 | 208 |
| Tax | −5 | −0 | — | −0 | −34 |
| Net profit | 18 | −12 | −19 | −9 | 174 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 159 | 144 | 124 | 122 | 336 |
| Equity | 149 | 137 | 118 | 109 | 282 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 9 | 6 | 6 | 13 | 54 |
| Total debt | 9 | 6 | 6 | 13 | 54 |
EBITDA margin
88.9%
This company
15.8%
Market median
+463% vs market
20212025
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20212025
Return on equity
61.5%
This company
18.4%
Market median
+234% vs market
20212025
Net profit margin
74.6%
This company
8.1%
Market median
+821% vs market
20212025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (5) | ||
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medinensis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Mikael Kahn | Board of Directors | 0 companies |
| Per Olof Erik Nibell | Board of Directors | 0 companies |
| Malin Cecilia Inghammar | Board of Directors | 0 companies |
| Maria Ulla Elisabeth Isacsson | Board of Directors | 0 companies |
| Per Åke Patrik Åkesson | Board of Directors | 0 companies |
| Eva Caroline Heijl | Deputy Board Member | 0 companies |
| Carl-Johan Martin Fraenkel | Board of Directors | 0 companies |